[ad_1]
Villers-lès-Nancy, 6 July 2022 – 7:00 p.m. (CET)
PRESS RELEASE
RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS’ MEETING
OF 28 JUNE 2022
Number of shares comprising the share capital: 15,174,125
Number of shares with voting rights: 15,005,340
Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,143,135
The Ordinary Annual General Meeting was held on Tuesday, 28 June 2022 at 5:00 p.m. at the Company’s headquarters and approved the separate parent company and consolidated financial statements for the 2021 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:
| Resolutions |
Results of the votes
|
| Approval of the annual financial statements | Resolution adopted by:
|
| Discharge of directors and discharge of the Statutory Auditors for the performance of their engagement | Resolution adopted by:
|
|
Resolution adopted by:
|
| Appropriation of earnings, setting the dividend | Resolution adopted by:
|
| Agreements and commitments governed by Articles L. 225-38 of the French Commercial Code | Resolution adopted by (*):
|
| Approval of the information on the compensation of corporate officers paid in or granted for fiscal 2021 and mentioned in Article L. 22-10-9 of the French Commercial Code | Resolution adopted by:
|
| Approval of the components of compensation paid in 2021 to Mr. Thierry CHAPUSOT, Chairman of the Board of Directors | Resolution adopted by:
|
| Approval of the components of compensation paid in 2021 to Mr. Dominique PAUTRAT, Chief Executive Officer | Resolution adopted by:
|
| Approval of the components of compensation paid in 2021 to Mr. Denis SUPPLISSON, Deputy CEO | Resolution adopted by:
|
| Approval of the components of compensation paid in 2021 to Mr. Grégoire de ROTALIER, Deputy CEO | Resolution adopted by:
|
| Approval of the compensation policy for the Chairman of the Board of Directors for 2022 | Resolution adopted by:
|
| Approval of the compensation policy for Mr. Dominique PAUTRAT, Chief Executive Officer until 22 April 2022 | Resolution adopted by:
|
| Approval of the compensation policy for Mr. Denis SUPPLISSON, Chief Executive Officer as from 23 April 2022 | Resolution adopted by:
|
| Approval of the compensation policy for Mr. Denis SUPPLISSON, Deputy Chief Executive Officer until 22 April 2022 | Resolution adopted by:
|
| Approval of the compensation policy for Mr. Grégoire de ROTALIER, Deputy Chief Executive Officer for 2022 | Resolution adopted by:
|
| Approval of the compensation policy for Directors | Resolution adopted by:
|
| Setting total annual compensation for directors for 2022 | Resolution adopted by:
|
| Authorisation to be given to the Board of Directors to proceed with buybacks of the Company’s shares | Resolution adopted by:
|
| Powers for formalities | Resolution adopted by:
|
(*) After deduction of excluded voting rights
Financial Calendar:
- Publication of H1 2022 Revenue: 3 August 2022.
About Equasens Group:
With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.
With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.
Listed on Euronext Paris™ – Compartment A
Included in the Euronext Tech Leaders segment and the European Rising Tech label
Indexes: MSCI GLOBAL SMALL CAP – GAÏA Index 2020 – CAC® SMALL and CAC® All-Tradable by inclusion
Eligible for the Deferred Settlement Service (“Service à Réglement Différé” – SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR0012882389 – Ticker Code: EQS
For all the latest news on Equasens Group go towww.equasens.com
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 – [email protected]
Media Relations:
FIN’EXTENSO – Isabelle APRILE
+33 (0)1 39 97 61 22 – [email protected]
[ad_2]
Source link
The content is by Globe Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
